Pfizer buys Bind with $40mm winning bid
Executive Summary
In early July, public drug delivery firm Bind Therapeutics Inc. filed a motion for court approval of a stalking horse bid from Pfizer Inc., which, at the time, had agreed to pay $19.75mm in cash for Bind’s assets and would assume certain contractual liabilities.
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
-
Drug Delivery
- Controlled Release
- Site Specific
-
Drug Delivery
-
Biotechnology
- Nanotechnology, Chips, etc.
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Includes Contract
- Payment Includes Cash
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice